July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Inhibition of CNV (choroidal neovascularization) by berberine
Author Affiliations & Notes
  • Rong Wen
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Peiyu Li
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
    Department of Ophthalmology, Second Affiliated Hospital, Dalian Medical University, Dalian, China
  • Zhijun Luo
    Department of Biochemistry, Boston University, School of Medicine, Boston, Massachusetts, United States
  • Yiwen Li
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Rong Wen, None; Peiyu Li, None; Zhijun Luo, None; Yiwen Li, None
  • Footnotes
    Support  Supported by NIH grants R01EY023666, P30-EY014801, Adrienne Arsht Hope for Vision fund, and an unrestricted grant from Research to Prevent Blindness, Inc. RW is the recipient of the 2015 Nelson Trust Award for Retinitis Pigmentosa from Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2633. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rong Wen, Peiyu Li, Zhijun Luo, Yiwen Li; Inhibition of CNV (choroidal neovascularization) by berberine. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2633.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Berberine is a benzylisoquinoline alkaloid found in a variety of medicinal herbs with anti-angiogenesis properties. The present work examines the potential of berberine in inhibiting CNV using the Matrigel CNV rat model.

Methods : CNV was induced in adult female Sprague-Dawley rats by subretinal injection of Matrigel. Berberine powder was added to PBS (10 µg/µl) as a suspension and mixed with Matrigel at a 1:3 ratio immediately before injecting to the right eyes (1.2 µl/eye). The left eyes were injected with Matrigel diluted at 3:1 with PBS only. Animals were killed 10 days later and perfused with a DiI solution to stain blood vessels. Eyes were collected and embedded in 5% agarose. Serial sections were cut on a vibratome to cover the entire Matrigel area and examined by confocol microscopy. CNV area was calculated and analyzed.

Results : The average CNV affected area in the in the control group is calculated to be 293.97±149.60 (x 1,000 µm2, mean±SD, n=7). The berberine treated eyes, on the other hand, had an average CNV area of 87.41±70.43 (x 1,000 µm2, mean±SD, n=8), significantly smaller than the control eyes (P<0.01).

Conclusions : Berberine significantly inhibits CNV in the subretinal Matrigel CNV model.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.